Related Experiment Video

Updated: May 16, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

The biochemical aspects of a non-ST-segment elevation acute coronary syndrome

Robert K Riezebos1, Freek W A Verheugt, Gerrit J Laarman

  • 1Department of Cardiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.

Reviews in Cardiovascular Medicine
|November 20, 2012
PubMed

Insights

Biomarkers like natriuretic peptides and C-reactive protein offer prognostic insights for acute coronary syndromes. Combining diverse cardiac biomarkers may improve risk assessment and guide therapy for better patient outcomes.

Area of Science:

  • Cardiology
  • Biomarker Research
  • Clinical Medicine

Background:

  • Acute coronary syndromes (ACS) present a spectrum of clinical severity, impacting patient prognosis.
  • Biomarkers of myocardial necrosis correlate with infarct size and patient outcomes, aiding management decisions.
  • Emerging research highlights neurohumoral mechanisms and inflammatory markers in ACS pathophysiology.

Purpose of the Study:

  • To explore the prognostic value of various cardiac biomarkers in acute coronary syndromes.
  • To investigate the role of natriuretic peptides and inflammatory markers in assessing myocardial damage and risk.
  • To evaluate the potential of combining diverse biomarkers for improved risk stratification and therapeutic guidance.

Main Methods:

  • Analysis of myocardial necrosis biomarkers to quantify cardiac damage.
  • Assessment of natriuretic peptides for information on the area at risk during ischemic events.
  • Evaluation of inflammatory biomarkers, such as C-reactive protein, in relation to atherosclerosis and acute ischemic events.

Main Results:

  • Natriuretic peptides emerge as significant prognostic biomarkers following myocardial ischemia.
  • C-reactive protein is linked to both atherosclerosis development and the risk of acute ischemic events.
  • Cardiac biomarkers collectively characterize the pathophysiology of acute coronary syndromes.

Conclusions:

  • Assessing combinations of pathobiologically diverse biomarkers may offer superior risk evaluation.
  • Utilizing a multi-biomarker approach can further dictate subsequent therapeutic strategies.
  • Prognostic biomarkers are crucial for guiding management decisions in patients with acute coronary syndromes.

More Related Videos

Application of Unsupervised Multi-Omic Factor Analysis to Uncover Patterns of Variation and Molecular Processes Linked to Cardiovascular Disease08:51

Application of Unsupervised Multi-Omic Factor Analysis to Uncover Patterns of Variation and Molecular Processes Linked to Cardiovascular Disease

Published on: September 20, 2024

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...